Efficacy of levetiracetam at 12 months in children classified by seizure type, cognitive status, and previous anticonvulsant drug use

Journal of Child Neurology

Volumn 20, Issue 7, 2005, Pages 590-594

  Mandelbaum, David E ^a,c   Bunch, Marjorie ^b   Kugler, Steven L ^b   Venkatasubramanian, Anuradha ^b   Wollack, Jan B ^b  

^a BROWN UNIVERSITY   (United States)

^b ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICONVULSIVE AGENT; ETIRACETAM; ZONISAMIDE;

ADOLESCENT; ADULT; AGGRESSIVENESS; ANOREXIA; ARTICLE; BEHAVIOR DISORDER; CHILD; CHILDHOOD DISEASE; COGNITION; COGNITIVE DEFECT; COMPULSION; CONTROLLED STUDY; DISEASE CONTROL; DISEASE EXACERBATION; DRUG EFFICACY; DRUG ERUPTION; DRUG METABOLISM; DRUG RESPONSE; DRUG USE; DYSESTHESIA; EDUCATION; FEMALE; FOCAL EPILEPSY; FREQUENCY ANALYSIS; GAIT DISORDER; GRAND MAL SEIZURE; HEADACHE; HUMAN; INFANT; INSOMNIA; INTRACTABLE EPILEPSY; IRRITABILITY; LETHARGY; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MENTAL INSTABILITY; MIXED SEIZURE; MOOD DISORDER; NAUSEA; PATIENT CODING; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SALIVATION DISORDER; SEIZURE; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME; VERTIGO; VOMITING;

EID: 24344444095     PISSN: 08830738     EISSN: None     Source Type: Journal    
DOI: 10.1177/08830738050200071001     Document Type: Article

References (14)

1. Ben-Menachem E, Falter U: Efficacy and tolerability of levetiracetam 3000mg/d in patients with refractory partial seizures: A multicenter, double-blind, responder-selected study evaluating monotherapy. Epilepsia 2000;41:1276-1283.
2. Cereghino JJ, Biton V, Abou-Khalil B, et al: Levetiracetam for partial seizures: Results of a double-blind, randomized clinical trial. Neurology 2000;55:236-242.
3. Shorvon SD, Lowenthal A, Janz D, et al: Multicenter double-blind, randomized, placebo-controlled trial of levetiracetam as add-on therapy in patients with refractory partial seizures. Epilepsia 2000;41:1179-1186.
4. Glauser TA, Pellock JM, Bebin EM, et al: Efficacy and safety of levetiracetam in children with partial seizures: An open-label trial. Epilepsia 2002;43:518-524.
5. Wheless JW, Ng Y: Levetiracetam in refractory pediatric epilepsy. J Child Neurol 2002;17:413-415.
6. Lagae LG, Buyse G, Ceulemans B: Effect of levetiracetam on behavior and alertness in children. Epilepsia 2003;44(Suppl 9):92.
7. Mandelbaum DE, Bunch ME, Kugler SL, et al: Efficacy of levetiracetam at one year in children classified by seizure type, cognitive status and prior anticonvulsant drug exposure. Epilepsia 2003;44(Suppl 9):93.
8. Mordekar SR, Peake D, Gosalakkal J, et al: Clinical experience of levetiracetam (Keppra) in children with intractable epilepsy: Preliminary results. Epilepsia 2003;44(Suppl 9):93.
9. French JA, Kanner AM, Bautista J, et al: Efficacy and tolerability of the new antiepileptic drugs II: Treatment of refractory epilepsy. Report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society. Neurology 2004;62:1261-1273.
10. Gower AJ, Hirsch E, Boehrer A, et al: Effect of levetiracetam, a novel antiepileptic drug, on convulsant activity of two genetic rat models of epilepsy. Epilepsy Res 1995;22:207-213.
11. Loscher W, Honack D: Profile of ucb L059, a novel anticonvulsant drug, in models of partial and generalized epilepsy in mice and rats. Eur J Pharmacol 1993;232:147-158.
12. Margineanu DG, Klitgaard H: Inhibition of neuronal hypersynchrony in vitro differentiates levetiracetam from classical antiepileptic drugs. Pharmacol Res 2000;42:281-285.
13. Kossoff EH, Bergey GK, Freeman JM, Vinning EP: Levetiracetam psychosis in children with epilepsy. Epilepsia 2001;42:1611-1613.
14. Miller GS: Pyridoxine ameliorates adverse behavioral effects of levetiracetam in children. Epilepsia 2002;43(Suppl 7):62.